Intracellular Protein–Drug Interactions Probed by Direct Mass Spectrometry of Cell Lysates

Rivkah Rogawski, Adi Rogel, Itai Bloch, Maayan Gal, Amnon Horovitz, Nir London, Michal Sharon*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Understanding protein–ligand interactions in a cellular context is an important goal in molecular biology and biochemistry, and particularly for drug development. Investigators must demonstrate that drugs penetrate cells and specifically bind their targets. Towards that end, we present a native mass spectrometry (MS)-based method for analyzing drug uptake and target engagement in eukaryotic cells. This method is based on our previously introduced direct-MS method for rapid analysis of proteins directly from crude samples. Here, direct-MS enables label-free studies of protein–drug binding in human cells and is used to determine binding affinities of lead compounds in crude samples. We anticipate that this method will enable the application of native MS to a range of problems where cellular context is important, including protein–protein interactions, drug uptake and binding, and characterization of therapeutic proteins.

Original languageEnglish
Pages (from-to)19637-19642
Number of pages6
JournalAngewandte Chemie - International Edition
Volume60
Issue number36
DOIs
StatePublished - 1 Sep 2021

Funding

FundersFunder number
Nancy and Stephen Grand Israel National Center for Personalized Medicine for providing drugs
Israel Science Foundation300/17
Università degli Studi di Firenze

    Keywords

    • analytical methods
    • drug discovery
    • drug screening
    • mass spectrometry
    • protein analysis

    Fingerprint

    Dive into the research topics of 'Intracellular Protein–Drug Interactions Probed by Direct Mass Spectrometry of Cell Lysates'. Together they form a unique fingerprint.

    Cite this